1.. Hyder JA, Allison MA, Criqui MH, Wright CM. Association between systemic calcified atherosclerosis and bone density.
Calcif Tissue Int 2007;80(5):301-6.
2.. Frye MA, Melton LJ 3rd, Bryant SC, Fitzpatrick LA, Wahner HW, Schwartz RS, et al. Osteoporosis and calcification of the aorta.
Bone Miner 1992;19(2):185-94.
3.. Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR. Rate of bone loss is associated with mortality in older women: a prospective study.
J Bone Miner Res 2000;15(10):1974-80.
4.. Mussolino ME, Madans JH, Gillum RF. Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study.
Ann Epidemiol 2003;13(10):692-7.
5.. Wang PS, Solomon DH, Mogun H, Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.
JAMA 2000;283(24):3211-6.
6.. Parhami F. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor?
Prostaglandins Leukot Essent Fatty Acids 2003;68(6):373-8.
7.. Parhami F, Garfinkel A, Demer LL. Role of lipids in osteoporosis.
Arterioscler Thromb Vasc Biol 2000;20(11):2346-8.
8.. Tankó LB, Bagger YZ, Nielsen SB, Christiansen C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women?
Bone 2003;32(1):8-14.
9.. Colles SM, Maxson JM, Carlson SG, Chisolm GM. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols.
Trends Cardiovasc Med 2001;11(3-4):131-8.
10.. Johnston CC Jr, Hui SL, Witt RM, Appledorn R, Baker RS, Longcope C. Early menopausal changes in bone mass and sex steroids.
J Clin Endocrinol Metab 1985;61(5):905-11.
11.. Rosen CJ, Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis.
Am J Med 2009;122(5):409-14.
12.. Parhami F, Mody N, Gharavi N, Ballard AJ, Tintut Y, Demer LL. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells.
J Bone Miner Res 2002;17(11):1997-2003.
13.. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients.
Arterioscler Thromb Vasc Biol 1997;17(4):680-7.
14.. Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications.
Clin Biochem 2007;40(9-10):575-84.
15.. Kim YH, Nam GE, Cho KH, Choi YS, Kim SM, Han BD, et al. Low bone mineral density is associated with dyslipidemia in South Korean men: the 2008-2010 Korean National Health and Nutrition Examination Survey.
Endocr J 2013;60(10):1179-89.
16.. Rhee EJ, Kim SY, Jung CH, Lhee HY, Lee WY, Kim SW. The correlation between lumbar spine bone mineral density and serum lipid profiles in apparently healthy Korean males. J Korean Soc Osteoporosis 2004;2(2):105-11.
17.. Suh YS. Relationship between bone mineral density and blood lipid in young and middle-aged men and pre-menopausal women. Korean J Health Promot 2007;7(4):238-44.
18.. Solomon DH, Avorn J, Canning CF, Wang PS. Lipid levels and bone mineral density.
Am J Med 2005;118(12):1414.
19.. Wu LY, Yang TC, Kuo SW, Hsiao CF, Hung YJ, Hsieh CH, et al. Correlation between bone mineral density and plasma lipids in Taiwan.
Endocr Res 2003;29(3):317-25.
20.. Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J, et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men.
Calcif Tissue Int 2004;74(2):136-42.
21.. Dennison EM, Syddall HE, Aihie Sayer A, Martin HJ, Cooper C. Hertfordshire Cohort Study Group. Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study.
QJM 2007;100(5):297-303.
22.. Hernández JL, Olmos JM, Ramos C, Martínez J, de Juan J, Valero C, et al. Serum lipids and bone metabolism in Spanish men: the Camargo cohort study.
Endocr J 2010;57(1):51-60.
23.. Adami S, Braga V, Gatti D. Association between bone mineral density and serum lipids in men.
JAMA 2001;286(7):791-2.
24.. Cui LH, Shin MH, Chung EK, Lee YH, Kweon SS, Park KS, et al. Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea.
Osteoporos Int 2005;16(12):1975-81.
25.. Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW. Relationship of obesity with osteoporosis.
J Clin Endocrinol Metab 2007;92(5):1640-6.
26.. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat.
Bone 2003;33(4):646-51.
27.. Maurin AC, Chavassieux PM, Frappart L, Delmas PD, Serre CM, Meunier PJ. Influence of mature adipocytes on osteoblast proliferation in human primary cocultures.
Bone 2000;26(5):485-9.
28.. Dragojevič J, Zupan J, Haring G, Herman S, Komadina R, Marc J. Triglyceride metabolism in bone tissue is associated with osteoblast and osteoclast differentiation: a gene expression study.
J Bone Miner Metab 2013;31(5):512-9.
29.. D'Amelio P, Pescarmona GP, Gariboldi A, Isaia GC. High density lipoproteins (HDL) in women with postmenopausal osteoporosis: a preliminary study.
Menopause 2001;8(6):429-32.
30.. Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, et al. Plasma lipids and osteoporosis in postmenopausal women.
Endocr J 2002;49(2):211-7.